Why not adopt the blacklist of yore?

doi:10.1136/bmj.a807

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ comment articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

L Sam Lewis, general practitioner

¹Surgery, Newport, Pembrokeshire SA42 0TJ

sam{at}garthnewydd.freeserve.co.uk

I suppose it is inevitable that the moral and political issue of copayment for cancer drugs will result in an arbitrary, bureaucratic directive, such as that offered by the unelected Lords Finlay and Crisp,1 whose rules I summarise:

(1) The drug or device is listed as one for which copayment is allowed.
(2) The patient should want the treatment (and have discussed the risks, etc).
(3) The clinician should have a reasonable belief that benefits outweigh the benefits of other treatment. …